ANATOMİ ANABİLİM DALI HAKKINDA          AKADEMİK KADRO          YÜRÜTÜLEN ÇALIŞMALAR          DUYURULAR

KİŞİSEL BİLGİLER          PROJELER          YAYINLAR

YAYINLARI :

DOKTORA TEZİ 

Değişik beyin bölgelerinde tromboksan A2'nin hemorajik şok oluşturulmuş sıçanlarda kardiyovasküler regülasyondaki rolünün incelenmesi. Uludağ Üniversitesi Bilimsel Araştırma Projeleri Birimi 2001-66

YAYINLAR

SCI, SSCI, AHCI İNDEKSLERİNE GİREN DERGİLERDE YAYINLANAN MAKALELER

Yalcin M, Savci V. Restoration of blood pressure by centrally injected U-46619, a thromboxane A2 analog, in hemorrhaged hypotensive rats: Invetigation of different brain areas. Pharmacology, 70: 177-187, 2004.

Galip N, Aydin C, Turkmen II, Yalcin M, Biricik H. Effect of supplemental yeast culture on blood parameters. Indian Veterinary Journal, 81: 1235-1238, 2004.

Sevimli A, Misirlioglu D, Polat U, Yalcin M, Akkoc A, Uguz C. The effects of vitamin A, pentoxyfylline and methylprednisolone on experimentally induced amyloid arthropathy in Brown layer chicks. Avian Pathology. 34(2): 143-149, 2005.

Yalcin M, Cavun S, Yilmaz MS, Savci V. The involvenment of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 372: 31-40, 2005.

Yalcin M, Cavun S, Yilmaz MS, Cengiz F, Savci V. Involvement of brain thromboxane A2 in hypotension induced by haemorrhage in rats. Clin. Exp. Pharma. Physiol. 32: 960-967, 2005.

Yilmaz MS, Yalcin M, Savci V. Cytidine 5’- diphosphocholine restores the blood flow of superior mesenteric and renal artery, prolongs the survival time in haemorrhaged anaesthetised rats. Clin. Exp. Pharma. Physiol. 33: 415-420, 2006.

Yalcin M, Ak F, Erturk M. The role of the central thromboxane A2 in cardiovascular effects of a phospholipase A2 activator melittin administrated intracerebroventricularly in normotensive conscious rats. Neuropetides 40: 207-212, 2006.

Yalcin M, Cavun S, Yilmaz MS, Savci V. Activation of central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, thromboxane A2 analog, in haemorrhaged rats. Brain Research 1118: 43-51, 2007.

Yalcin M, Erturk M.: The involvement of the central cholinergic system in the pressor and bradycardic effects of centrally administrated melittin in normotensive conscious rats. Neuropetides 41: 103-110, 2007.

Yalcin M, Altunbas K. Streptozotocin induced type 1 diabetes mellitus on haematology and erythrocyte sodium potassium in mice. Indian Veterinary Journal 84 (4): 365-367, 2007.

Yalcin M, Ak F, Cangul IT, Erturk M. The effect of centrally administered erythropoietin on cardiovascular and respiratory system of anaesthetized rats. Autonomic Neuroscience: Basic and Clinical 134: 1-7, 2007.

Yalcin M, Savci V. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: The investigation of peripheral mechanisms. Neuropetides 41(6):465-75 2007.

Mousa SA, Bergh JJ, Dier E, Rebbaa A, Oconnor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis. 11(2):183-90, 2008.

Yilmaz MS, Coskun C, Suzer O, Yalcin M, Mutlu D, Savci V. Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors. European Journal of Pharmacology 584(1):125-36, 2008.

Aydin C, Yalcin M. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid. Prostaglandins Leukot Essent Fatty Acids, 78: 361-368, 2008. (Sorumlu Yazar puanı)

Yilmaz MS, Coskun C, Yalcin M, Savci V. CDP-choline prevents cardiac arrhythmias and lethality induced by short-term myocardial ischemia-reperfusion injury in the rat: involvement of central muscarinic cholinergic mechanisms. Naunyn-Schmiedeberg Archives of Pharmacology, 378(3): 293-301, 2008.

Yalcin M, Aydin C. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism. Clin Exp Pharmacol Physiol. 36(4): 447-453, 2009.

Bridoux A, Cui H, Dyskin E, Yalcin M, Mousa SA. Semisynthesis and Pharmacological Activities of Tetrac Analogs: Angiogenesis Modulators. Bioorganic & Medicinal Chemistry Letters 19 (12): 3259-63, 2009.

Yalcin M, Savci V, Jochem J. Involvement of the cholinergic system in the central histamine-induced reversal of critical haemorrhagic hypotension in rats. J Physiol Pharmacol. 60 (2): 133-7, 2009.

Kemp MM, Kumar A, Mousa S, Dyskin E, Yalcin M, Ajayan P, Linhardt RJ, Mousa SA. Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties. Nanotechnology 20: 455104 (7pp), 2009.

Yalcin M, Aydin C, Savci V. Cardiovascular effect of peripheral injected melittin in normotensive conscious rats: mediation of the central cholinergic system. Prostaglandins Leukot Essent Fatty Acids 81: 341-7, 2009.

Yalcin M, Bharali DJ, Lansing L, Dyskin E, Mousa SS, Hercbergs A, Davis FB, Davis PJ, Mousa SA. Tetraidothyroacetic Acid (Tetrac) and Tetrac Nanoparticles Inhibit Growth of Human Renal Cell Carcinoma Xenografts. Anticancer Research, 29, 3825-3831, 2009.

Mousa SA, Gallati C, Simone T, Dier E, Yalcin M, Dyskin E, Thangirala S, Hanko C, Rebbaa A. Dual targeting of the antagonistic pathways mediated by sirt1 and txnıp as a putative approach to enhance the efficacy of anti-aging interventions. Aging (ALBANY NY). 1(4): 412-24, 2009.

Rebbaa A, Chu F, Sudha T, Gallati C, Dier U, Dyskin E, Yalcin M, Bianchini C, Shaker O, Mousa SA. The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor. Anticancer Res. 29: 4473-81, 2009.

Coskun C, Avci B, Ocak N, Yalcin M, Dirican M, Savci V., Effect of repeatedly given CDP-choline on cardiovascular and tissue injury in spinal shock conditions: investigation of the acute phase. Journal of Pharmacy and Pharmacology 62(4):497-506 2010.

Jochem J, Savci V, Filiz N, Rybus-Kalinowska B, Fogel WA, Yalcin M.Involvement of the histaminergic system in cytidinediphosphocholine-induced reversal of critical haemorrhagic hypotension in rats. J. Physiol Pharmacol. 61(1):37-43 2010.

Yalcin M, Bharali DJ, Dyskin E, Dier E, Lansing L, Mousa SS, Davis FB, Davis PJ, Mousa SA. Tetraiodothyroacetic Acid and Tetraiodothyroacetic Acid Nanoparticle Effectively Inhibit the Growth of Human Follicular Thyroid Cell Carcinoma. Thyroid 20(3):281-6 2010.

Bridoux A, Cui H, Dyskin E, Schmitzer AR, Yalcin M, Mousa SA. Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators. Bioorganic & Medicinal Chemistry Letters  20: 3394-8, 2010.

Bridoux A, Cui H, Dyskin E, Schmitzer AR, Yalcin M, Mousa SA. Corrigendum to “Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators. Bioorganic & Medicinal Chemistry Letters 20 (2010) 3394” Bioorganic & Medicinal Chemistry Letters 20: 5585, 2010.

Jacoby DB, Dyskin E, Yalcin M, Kesavan K, Dahlberg W, Ratliff J, Johnson E, Mousa SA. Potent Pleiotropic Anti-angiogenic Effects of TM601, a Synthetic Chlorotoxin Peptide. Anticancer Research, 30(1):39-46, 2010.

Yalcin M, Dyskin E, Lansing L, Bharali DJ, Mousa S, Bridoux A, Hercbergs AH, Lin HY, Davis FB, Glinsky GV, Davis PJ, Mousa SA. Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Human Medullary Carcinoma of the Thyroid. J. Clin. Endoc. Met. 95(4):1972-80 2010.

Yalcin M. Central mechanism underlying pressor and bradycardic effect of intracerebroventricularly injected arachidonic acid. Can J Physiol Pharmacol. 89(2): 127-33,  2011.

Phillips PG, Yalcin M, Cui H, Abdel-Nabi H, Sajjad M, Bernacki R, Veith J, Mousa SA. Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin. Anticancer Res. 31(2): 411-9, 2011.

Yalcin M, Aydin C. The role of the central arachidonic acid-thromboxane A2 cascade in cardiovascular regulation during hemorrhagic shock in rats. Prostaglandins Leukot Essent Fatty Acids. 85(2): 61-6, 2011.

Mousa SA, Yalcin M, Bharali DJ, Meng R, Tang HY, Lin HY, Davis FB, Davis PJ. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts. Lung Cancer, 76(1): 39-45, 2012.

Sevimli A, Yalcin M, Cangul IT, Aydin S. Investigation of Serum Amino Acid and Serum Amyloid A (SAA) Levels in Chickens with Amyloid Arthropathy. Veterinary Quarterly, 32(1): 17–23, 2012.

Altinbas B, Topuz BB, Yilmaz MS, Aydin C, Savci V, Jochem J, Aydin S, Yalcin M. The mediation of the central histaminergic system in the pressor effect of intracerebroventricularly injected melittin, a phospholipase A2 activator, in normotensive rats. Prostaglandins Leukot Essent Fatty Acids, 87: 153-158, 2012.

Rebbaa A, Patil G, Yalcin M, Sudha T, Mousa SA. OT-404, multi-targeted anti-cancer agent affecting tumor proliferation, chemo-resistance, and angiogenesis. Cancer Lett. 332(1): 55-62, 2013.

Yalcin M, Lin HY, Sudha T, Bharali DJ, Meng R, Tang HY, Davis FB, Stain SC, Davis PJ, Mousa SA. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. Horm Cancer. 4(3): 176-85 2013.

Bharali DJ, Yalcin M, Davis PJ, Mousa SA. Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. Nanomedicine (Lond) 8(12): 1943-54, 2013.

Davis PJ, Yalcin M, Lin HY, Tang HY, Hercbergs A, Leith JT, Davis FB, Luidens MK, Mousa SA. Incomplete success of angioinhibitor therapy in cancer: estimation of contribution of pro-angiogenic activity of patient thyroid hormone. J Cancer Sci Ther. 5: 441-445, 2014.

Davis PJ, Lin HY, Sudha T, Yalcin M, Tang HY, Hercbergs A, Leith JT, Luidens MK, Ashur-Fabian O, Incerpi S, Mousa SA. Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis. Onco Targets Ther. 7: 1619-24, 2014.

Topuz BB, Altinbas B, Yilmaz MS, Saha S, Batten TF, Savci V, Yalcin M. The effect of centrally injected CDP-choline on respiratory system; involvement of phospholipase to thromboxane signaling pathway. Respir Physiol Neurobiol. 195: 50-8 2014.

Topuz BB, Altinbas B, Ilhan T, Yilmaz MS, Erdost H, Saha S, Savci V, Yalcin M.Centrally administered CDP-choline induced cardiovascular responses are mediated by activation of the central phospholipase-prostaglandin signaling cascade. Brain Res. 1563: 61-71, 2014.

Altinbas B, Topuz BB, İlhan T, Yilmaz MS, Erdost H, Yalcin M. Activation of the central histaminergic system mediates arachidonic-acid-induced cardiovascular effects. Can J Physiol Pharmacol. 92(8): 645-54, 2014.

Sudha T, Yalcin M, Lin HY, Elmetwally AM, Nazeer T, Arumugam T, Phillips P, Mousa SA. Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin. Cancer Lett. 350(1-2): 25-33, 2014.

Tezcan G, Tunca B, Bekar A, Yalcin M, Sahin S, Budak F, Cecener G, Egeli U, Demir C, Guvenc G, Yilmaz G, Erkan LG, Malyer H, Taskapilioglu MO, Evrensel T, Bilir A. Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell lines. Cell Mol Neurobiol. 35(2): 175-87, 2014.

Coskun C, Avci B, Yalcin M, Yermezler A, Yilmaz MS, Savci V. Protective effect of CDP-choline on ischemia-reperfusion-induced myocardial tissue injury in rats. Ir J Med Sci. 183(4): 539-48, 2014.

Altinbas B, Yilmaz MS, Savci V, Jochem J, Yalcin M. Centrally injected histamine increases posterior hypothalamic acetylcholine release in hemorrhage-hypotensive rats. Auton Neurosci. 187: 63-9, 2015.

Erkan LG, Altinbas B, Guvenc G, Alcay S, Toker MB, Ustuner B, Udum Kucuksen D, Yalcin M. Brain thromboxane A2 via arachidonic acid cascade induces the hypothalamic-pituitary-gonadal axis activation in rats. Auton Neurosci. 189: 50-5, 2015. 

Yilmaz MS, Altinbas B, Guvenc G, Erkan LG, Avsar O, Savci V, Udum Kucuksen D, Arican I, Yalcin M. The role of centrally injected nesfatin-1 on cardiovascular regulation in normotensive and hypotensive rats. Auton Neurosci. 2015.

DİĞER DERGİLERDE YAYINLANAN MAKALELER

Cengiz F, Yalçın M. Holştayn ve esmer ırk ineklerde kurudaki dönemde bazı kan parametrelerinin incelenmesi. Uludağ Üniversitesi Veteriner Fakültesi Dergisi, 19: 83-86, 2000.

Cengiz F, Yalçın M. Koyunlarda metabolizma kafesinde tutulmanın etkilerinin incelenmesi. Uludağ Üniversitesi Veteriner Fakültesi Dergisi, 20 (3): 59-65, 2001.

Aydın C, Kennerman E, Galip N, Yalçın M, Ak F, Kayaalp C.: Hepatik iskemi-reperfüzyon hasarının sıçanlarda alyuvar ve plazma elektrolit dengesi bazı serum biyokimyasal parametreleri ve karaciğer histolojisi üzerine etkisi. Veteriner Fakültesi Dergisi, 23 (1,2,3): 77-82, 2004.

Yalçın M, Galip N. Influence of acute serious haemorrhagagic shock on erythrocyte glutathione and sodium-potassium contents. Journal of Faculty of Veterinary Medicine 24: 47-52, 2005.

Yalçın M, Yağcı A. Alterations In Some Blood Parameters After High Level Ethanol Intake. Journal of Faculty of Veterinary Medicine 24: 15-19, 2005.

Köktentürk R, Yalçın M. Kardiyovasküler düzenlemede nükleus traktus solitarius’un rolü. Veteriner Fakültesi Dergisi, 30 (1): 53-59, 2011.

Süzer B, Altınbaş B, Seyidoğlu N, Arıcan İ, Orman A, Yıldız H, Yalçın M. The Effects of Supplemental Saccharomyces cerevisiae and Phytase on Growth Performances and Plasma Biochemical Parameters of Broiler Chickens. Uludag Universitesi Veteriner Fakültesi Dergisi, 2015   

KİTAPLAR

Yalçın M. Temel Veteriner Fizyoloji 3 bölüm yazarlığı Sayfa: 48-65, 90-113, 156-172. Editör Cengiz F,  Anadolu Üniversitesi Açık Öğretim Fakültesi Yayın Evi, Eskişehir, 2011. ISBN 978-975-06-1052-3.

Yalçın M. Evcil Hayvanların Fonksiyonel Anatomisi ve Fizyolojisi Kitabı Bölüm 9 Kardiyovasküler Sistem Sayfa: 228-260 Çeviri Editörü Çötelioğlu Ü, Özcan M. Nobel Akademik Yayıncılık Ankara 2012 ISSN 978-605-133-256-7.